Skip to main content
. 2021 Apr 9;14(4):348. doi: 10.3390/ph14040348

Figure 1.

Figure 1

Price regulation of biosimilar medicines in Spain. 1 According to Royal Decree 177/2014, of 21 March, regulating the reference price system and the system of homogeneous groups of medicinal products in the National Health System. 2 According to Law 9/2017 of 8 November on public sector contracts.